/Dr. Jonathan Wingfield
Applying Acoustic Mass Spectrometry Technology to Biochemical Screening and Beyond
Applying Acoustic Mass Spectrometry Technology to Biochemical Screening and Beyond
19 Dec 2018

Dr. Jonathan Wingfield , Principal Scientist at AstraZeneca, discusses the development of acoustic mass spectrometry technology for high-throughput screening. Through the combination of acoustic technology from Labcyte and mass spectrometry systems from Waters, acoustic mass spectrometry provides rapid sample processing and analysis of a wide range of molecular targets, saving crucial time and reagents costs needed to screen millions of compounds within AstraZeneca’s small molecule and discovery programs.

Related Scientists

Related Content